Bioresorbable Scaffolds Market Size, Analytical Overview, Growth Factors, Demand and Trends Forecast to 2023

Market Outlook

The global bioresorbable scaffolds market is expected to touch a towering valuation by exhibiting 18.9% CAGR from 2017 to 2023 (forecast period). High prevalence of cardiovascular disorders is the primary driver of the market. According to a 2014 report by the World Health Organization (WHO), cardiovascular diseases can account for a majority of deaths globally. Rising rates of obesity, diabetes, and sedentary lifestyle of patients can all contribute to the market growth.

Increasing government support and investment for better medical techniques and breakthroughs of techniques in cardiovascular surgeries can fuel the bioresorbable scaffolds market. Biodegradable nature of these stents which allow for recovery of vessel vasoreactivity can play a pivotal role in the market in the coming years. Use of polymers as a coating for stents for providing adequate radial strength will open up new growth avenues.

But availability of alternative therapies can restrain market growth.

Segmentation Analysis:

The global bioresorbable scaffolds market is segmented by material, type, application, and end-user.

By material, it is segmented into polycarbonate scaffold, polymeric scaffold, absorbable magnesium stent (AMS), and others. Polymeric and polycarbonate scaffold segments can account for a large market share due to increasing use of PCI procedures and preference of polymer-based stents.

By type, it is segmented into paclitaxel-eluting device, drug eluting coronary scaffolds, sirolimus-eluting device, everolimus-eluting device, and novolimus-eluting device.

By application, it is segmented into regulation of blood flow control, peripheral vascular intervention, and others.

By end-user, it is segmented into clinics, hospitals, and others. Hospitals can account for a large market share due to preference of hospitals by patients for diagnostic and surgical procedures. Rapid rate of cardiovascular surgeries can drive the segment growth exponentially.

Browse Complete Report: https://www.marketresearchfuture.com/reports/bioresorbable-scaffolds-market-1251

Regional Analysis

Europe, the Middle East & Africa (MEA), Asia Pacific, and the Americas are regions covered in the bioresorbable scaffolds market report.

The Americas accounted for close to 40% market share in 2016. Large geriatric population, large share of the regional population plagued by obesity and diabetes, and presence of prominent market players are factors bound to propel demand for bioresorbable scaffolds in the region. High stress levels, lack of exercise, and deskbound lifestyle of patients are other drivers positively impacting the bioresorbable scaffolds market. High incidence of pulmonary artery disease, coronary artery disease, and other diseases which can harden or weaken arteries can also be a vital growth determinant in the market.

Europe has the second largest market share due to a large healthcare budget, patient-friendly reimbursement policies, and presence of developed economies of Italy, France, and Germany. Rising focus of players in the region to focus on clinical trials of stents and rise of pulmonary coronary interventional (PCI) procedures

The APAC region can account for the fastest growth rate due to a large patient pool, large number of skilled surgeons, and high incidence of cardiovascular disorders. Furthermore, reduction in prices of stents by governments for making it affordable for patients across all economic strata can bode well for the market within the region. 

Automated Suturing Device Market Research Forecast, Regional, Trends and Analysis to 2023

Surgical sutures devices are used for wound closure or repair injuries. These devices have their application in ophthalmology, orthopedic, gynecology, cardiovascular surgery, orthopedic surgery, laparoscopy and other specialties in healthcare. Surgical suture devices can be automated or manually used suture devices. Suture needle is primarily used for surgical site closure. Automated devices can be disposable or reusable. Disposable surgical suture devices are most widely used because of safety concerns to the patient and prevention of surgical site infection.

Key players in the automated devices market are Ethicon Inc. (Subsidiary of Johnson & Johnson) (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc. (Ireland), DemeTECH Corporation (U.S.),  Smith & Nephew plc (U.K.), Péters Surgical (France), EndoEvolution LLC (U.S.),  Boston Scientific Corporation (U.S.) and Sutures India Pvt. Ltd. (India). The main focus of these players is tapping the market in developing regions across the globe.

Key developments:

Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.

Avail Sample Copy before Purchase at: https://www.marketresearchfuture.com/sample_request/1207

Sutures are sterile surgical instruments used for the closure of surgical incision or wound. Sutures are either automated or manually operated devices. Demand for automated suturing devices is increasing due to an increase in the number of surgeries performed in the hospital, demand of safe closure of surgical site, prevention of hospital acquired infection, and improved quality of healthcare.

Intended Audience

• Medical device manufacturers
• Medical device suppliers
• Contract Research Organizations (CROs)
• Research and Development (R&D) Companies
• Academic Medical Institutes and Universities

There is an increasing demand for automated suturing devices in the market owing to an increasing number of surgical procedures in hospitals and rising prevalence of chronic diseases. The market is further stimulated by a technology advancement in surgical devices having applications in various fields of medicine such as dentistry, gynaecology, cardiology, urology, and others.

Ethicon Inc.:

Ethicon Inc. is a subsidiary of Johnson & Johnson, manufacturing surgical sutures and wound closure devices. Enseal X1 is a suturing devices designed for use in open surgical procedures. Harmonic HD 1000 is designed of laparoscopic surgery.

February 2017: Ethicon, Inc. today announced an agreement to acquire Torax Medical, Inc., a private medical device company manufacturing and marketing the LINX Reflux Management System, a novel minimally invasive device for the surgical treatment of GERD. This acquisition will enable the company to offer patients effective alternative to the anatomy-altering laparoscopic Nissen fundoplication surgical procedure. LINX Reflux Management System comprises of interlinked titanium beads with magnetic cores. LINX is currently used by physicians in over 300 hospitals in the U.S. and Europe. This acquisition is a part of strategic approach advancement in innovation and investment in esophageal health.

Brows full Detailed Report at: https://www.marketresearchfuture.com/reports/automated-suturing-devices-market-1207

Autoimmune Disease Diagnostics Market Size, significant challenges, Specifications, Analysis Forecast To 2023

Market Synopsis

Market Research Future (MRFR) asserts that the global autoimmune disease diagnostics market is likely to register a CAGR of 7.6% during the forecast period (2018-2023) owing to an increased prevalence of autoimmune diseases worldwide. Autoimmune disease is considered as a disorder where the body’s own immune system starts to attack the healthy cells in place of the foreign particles and disease-causing agents. Auto antibody test, antinuclear antibody test, complete blood count, C-reactive protein, and erythrocyte sedimentation rate are some of the tests performed for diagnosis of the autoimmune disease. 

Market Potential and Pitfalls

The global autoimmune disease diagnostics market is likely to experience an upsurge owing to the increased prevalence of autoimmune disease, surging awareness regarding autoimmune diseases, and rising expenditure on healthcare. The increasing spending on R&D activities coupled with the aggressive strategies adopted by the top market players like new product launches along with mergers and acquisitions are anticipated to contribute to the market growth across the globe. For instance, Abbott acquired Alere Inc. in October 2017 for USD 5300 million. The deal will enable Abbott to gain control over USD 7000 million diagnostics sales of Alere Inc. and also strengthen their position in the global market.

The increasing occurrences of several diseases like rheumatoid arthritis and Hashimoto’s thyroiditis are likely to influence the market across the globe. Several initiatives taken by the government regarding autoimmune disease diagnosis are further contributing to its growth. As per the American Autoimmune Related Diseases Association, approximately 50 million people from America are suffering from autoimmune related disorders. Such factors are likely to create immense opportunities to the growth of the market.

On the contrary, the surging false positive results along with the price war among the companies are the top barriers likely to vitiate the market growth to some extent during the appraisal period. Moreover, the dearth of education and experience of the lab personnel in diagnosing certain autoimmune diseases are further estimated to slow down the market growth.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715

Urgent Care Apps Market : Outlook Continues to Remain Positive by 2017 – 2023

Market Synopsis

The global market for urgent care apps was valued at USD 314.2 million in 2017 and can expect revenues of USD 2597.8 Mn by the end of 2023, says Market Research Future (MRFR). MRFR perceives the market to progress at a tremendous CAGR of 42.20% during the forecast period (2018-2023).

Market Boosters and Key Barriers

Urgent care apps let the user connect with a registered nurse who can answer any medical questions that the user has, and a licensed physician can give a call in a few minutes if the need arises. Moreover, patients seeking medical care for either themselves or others can make use of urgent care apps during an emergency and get the needed help from online doctors. At present, the demand for post-hospital apps during post-hospital care is increasing among patients at a significant pace.

The urgent care apps are witnessing a sharp rise in demand across the globe as the use of smartphones has surged in recent years. These factors are also supplemented by the penetration of 3G and 4G networks. Besides, the increasing focus on patient-centric healthcare delivery around the world will work in favor of the market in subsequent years. 

On the contrary, poor internet connectivity, especially in emerging countries, could decelerate market growth to some extent. With that said, the expanding population of smartphone users, along with rising awareness about medication management apps, will ensure a smooth run for the market in the years to come.

Market Opportunities

The worldwide urgent care apps market can expect robust growth opportunities with the launch of 5G internet services in the near future. Patients will be able to make use of call conferencing as well as live consultation features of smartphones backed by high-speed internet. This is projected to be an impactful factor accelerating the demand in the urgent care apps market. To elaborate, 5G network in mobile services offers a variety of advantages in terms of high speed, security, latency, energy, and reliability.

Market Segmentation

The worldwide urgent care apps market has been segmented on the basis of type and clinical area.

With respect to the type, the urgent care apps market is considered for emergency care triage apps, in-hospital communication & collaboration apps, and post-hospital apps.

Depending on the clinical area, the urgent care apps market covers trauma, stroke, cardiac conditions, and others. The trauma segment has the maximum coverage of the market based on the hike in incidences of road accidents necessitating trauma care and rising awareness regarding trauma cases. Yet, the cardiac conditions segment will be noting the fastest growth on account of the increasing realization of the advantages of urgent care apps in managing critical cardiac conditions.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/urgent-care-apps-market-6677

Steam Autoclave Market : Information, Figures and Analytical Insights 2018 – 2023

Global Steam Autoclave Market: Drivers & Trends

The presence of key manufacturers of the steam autoclave devices is intensifying the competition among them, which is taking the global steam autoclave market to surge at a considerable level. The surgical procedures are growing owing to the rise in the chronic diseases that needs proper treatments. Therefore, the patient base is increasing in this case, especially in the developing countries owing to the proliferation of population in this region. These factors above are evenly propelling the adoption of the steam autoclave and which in turn, is boosting the growth of the steam autoclaves market.

Market Insights

According to the reports published by Market Research Future Reports, the global steam autoclave market is probable to nurture significantly as it held a valuation of USD 1.78 billion in 2017 and is projected to register at a CAGR of 8.9% by 2023. Steam autoclaves are used for sterilization purposes where the process is non-toxic and inexpensive.

Apart from this, the rising patient-centric approach and efforts are taken to reduce several side-effects and other infections, which in turn, are propelling adaptation of the steam autoclaves. Thus, these factors are also contributing to the best of it in the growth of the global steam autoclaves market. Also, the introduction of technologically advanced, which has E-beam and gamma irradiation are also influencing the growth of the global steam autoclave market on the positive note. Additionally, product flexibility and low cost of new products are probable to support the growth of the market.

As per the research, the growth of the steam autoclaves market is also gaining traction owing to the presence of strict regulations to ensure the safety of the patients and the growing presence of advanced healthcare facilities.

Market Segmentation

According to the MRFR reports, the global steam autoclave market has been segmented into product type, technology, end user, and application.

By the mode of product type, the market has been segmented into the tabletop, vertical, horizontal, floor standing, and high pressure.

By the mode of technology, the market has been segmented into gravity displacement, pre-vacuum, and steam flush pressure pulse.

By the mode of technology, gravity displacement segment is expected to have the largest share of the market owing to its easy usage features and obstacle-free penetration. Wherein, pre-vacuum technology is predicted to cultivate at the fastest CAGR owing to the rising demand for the technology and high effectiveness in sterilizing porous substances.

By the mode of end user, the market has been segmented into hospitals & clinics, healthcare organizations, academic & research institutes, and other end users.

By the mode of application, the market has been segmented into medical, dental, laboratory, and others.

For More Details Browse Complete Report @ https://www.marketresearchfuture.com/reports/steam-autoclave-market-6645

Sinus Dilation Devices Market : Latest Innovations, Drivers and Industry Key Events 2018 – 2023

Market Analysis

The global sinus dilation devices market is expected to register a 8.1% CAGR during the forecast period of 2018 to 2023 and grow to valuation of USD 5,778 Mn by 2023 end reported Market Research Future (MRFR).

The clinical condition of inflamed sinus cavities present around the nasal cavity that obstructs the natural draining mechanism of the nose is called sinusitis. The sinus dilation devices aids in relieving the sinus cavity opening and eliminating the drainage problem. Acute sinusitis is triggered due to cold and allergies, whereas, bacterial invasion results in chronic sinusitis. The increase in cases of chronic sinusitis due to languid immunity of people is likely to increase the demand for sinus dilation device. Technical advancement is boosting the adoption of sinuplasty (sinus dilation), among patients, over traditional sinusitis surgery method. These are the market dynamics expected to drive the global sinus dilation device market. On the flip side, challenges like drugs preference over surgeries and lack of trained otolaryngologists are anticipated to impede the market escalation. 

Segmental Overview

MRFR in its report encompasses all the factors influencing the global sinus dilation devices market. The segmental analysis of the market offers a clear understanding of the sinus dilation devices market. Hence, the global sinus dilation devices market study is segmented by product, procedure, by patient type and end-user.

On the basis of product, the sinus dilation devices market has been segmented into sinus stents, balloon dilation, endoscope, functional endoscopic sinus surgery (FESS) instruments set, and handheld instruments. The endoscope segment has been further narrowed down to rhinoscopy and sinoscopy. The drug eluting feature of the sinus stents, resists inflammation and scarring, hence, makes implantation extremely feasible for patients. Owing to the benefits of the stents the sinus stent segment is anticipated to register the highest CAGR in the upcoming years.

On the basis of procedure, the sinus dilation devices market has been segmented into hybrid sinus dilation procedure, standalone sinus dilation procedures, and others. Advancements in medical infrastructure is encouraging patients to opt sinus surgeries. The sinus dilation procedures segment is expected to gain traction for generating the largest revenue due to an increase in the number of patients availing for complex sinus surgeries. On the basis of patient type, the sinus dilation devices market is segmented into pediatric and adults. On the basis of end-user, the sinus dilation devices market is segmented into hospitals, ENT clinics, diagnostic centers, research centers, and others.

Browse Complete Report: https://www.marketresearchfuture.com/reports/sinus-dilation-devices-market-6644

Adrenocortical Carcinoma Treatment Market to Reflect Impressive Growth Rate During 2018 to 2023

The overall 5-year mortality rate of 75 – 90% and an average survival from the time of diagnosis of 14.5 months. The rising incidence rate, a rise in the number of drugs in clinical trials for specific chemotherapeutics, and the increase in risk-factors are anticipated to drive the growth of the market during the assessment period. According to the International Pediatric Adrenocortical Tumor Registry, the female-to-male ratio for adrenocortical carcinoma is approximately 2.5-3:1. Inherited disorders such as Li-Fraumeni syndrome (LFS), Beckwith-Wiedemann syndrome (BWS), and Carney complex are linked with increased incidences of adrenocortical carcinoma. According to the survey by Endocrine Society, 2014, adrenocortical carcinoma comprises an approximate 3% to 10% of malignancies in LFS and over 5-15% of malignancies in BWS.  However, differentiation of benign and malignant tumor in the initial stages needs proper evaluation. The pathohistological diagnosis also remains challenging.  These factors coupled with the lack of oncology experts may restrain the growth of the market during the forecast period.

On a regional basis, the adrenocortical carcinoma treatment market in the Americas is anticipated to dominate the market during the forecast period. The market growth in this region is owing to the advanced healthcare expenditure and advancements in medical device technologies. Moreover, higher demand for quality products and the availability of reimbursement policies are expected to contribute to the market growth in this region.

Currently, the global adrenocortical carcinoma treatment market is dominated by several players. The prominent players in this market are involved in new product launches, strategic partnerships to expand their product portfolio.  For instance, in April 2015, ArQule, Inc. announced ARQ 087 is currently in a Phase 2 trial in patients with Intrahepatic Cholangiocarcinoma (ICC) with FGFR2 fusions and a Phase 1b trial in adrenocortical tumors and tumors with FGFR translocations, amplification, and mutations. ARQ 087 is a potent FGFR (Fibroblast Growth Factor Receptor) inhibitor. Also, in March 2018, the University of Colorado Anschutz Medical Campus presented novel models to recognize genetic targets and test promising treatments in adrenocortical carcinoma at the ENDO Conference exploring a new therapeutic option.

Access Report @ https://www.marketresearchfuture.com/reports/adrenocortical-carcinoma-treatment-market-6567

The global adrenocortical carcinoma treatment market has been segmented into type, therapy, and end-user.

Some of the key players in the global adrenocortical carcinoma market are Pfizer Ltd., Arqule, EnGeneIC Ltd, Exelixis, Inc., Millendo Therapeutics, Inc., Merck & Co., Orphagen Pharmaceuticals, Inc., HRA Pharma, Bristol-Myers Squibb Company, General Electric Company, WG Critical Care, LLC, Mylan N.V., Fresenius Kabi AG, Sinovision Technologies (Beijing) CO. ,Ltd., Hitachi, Ltd., NeuroLogica Corp., and Digirad Corporation.